Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure

Cowper, 2001, Nephrogenic fibrosing dermopathy, Am J Dermatopathol, 23, 383, 10.1097/00000372-200110000-00001 Cowper, 2000, Scleromyxedema-like cutaneous diseases in renal-dialysis patients, Lancet, 356, 1000, 10.1016/S0140-6736(00)02694-5 Goveia, 2002, CDC public health dispatch, MMWR Morb Mortal Wkly Rep, 51, 25 Kohl, 2002, Disease debut, Dermatol Times, 23, 1 Weedon, 1998, Cutaneous mucinoses, 339 Leiferman, 1999, Cutaneous eosinophilic diseases, 1129 Clauw, 1995, Eosinophilic rheumatic disorders, Rheum Dis Clin North Am, 21, 231, 10.1016/S0889-857X(21)00381-1 Webster, 1993, The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis), J Am Acad Dermatol, 28, 105, 10.1016/0190-9622(93)70021-K Godby, 1998, Fatal scleromyxedema, J Am Acad Dermatol, 38, 289, 10.1016/S0190-9622(98)70567-5 Leffell, 1994, The distribution of HLA antigens and phenotypes among donors and patients in the UNOS registry, Transplantation, 58, 1119, 10.1097/00007890-199411000-00011 Rongioletti, 2001, Updated classification of papular mucinosis, lichen myxedematosus and scleromyxedema, J Am Acad Dermatol, 44, 273, 10.1067/mjd.2001.111630 Moulin, 1998, Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts, Exp Cell Res, 238, 283, 10.1006/excr.1997.3827 Clark, 1993, Regulation of fibroplasia in cutaneous wound repair, Am J Med Sci, 306, 42, 10.1097/00000441-199307000-00011 Ehrlich, 1994, Morphological and immunochemical differences between keloid and hypertrophic scar, Am J Pathol, 145, 105 Santucci, 2001, Keloids and hypertrophic scars of caucasians show distinctive morphologic and immunophenotypic profiles, Virchows Arch, 438, 457, 10.1007/s004280000335 Kirk, 1995, Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1, J Biol Chem, 270, 3423, 10.1074/jbc.270.7.3423 Kirk, 1999, Il-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death, Biochem Biophys Res Commun, 255, 129, 10.1006/bbrc.1999.0155 Phan, 1999, The myofibroblast as an inflammatory cell in pulmonary fibrosis, Curr Top Pathol, 93, 173, 10.1007/978-3-642-58456-5_18 Desmouliere, 1993, Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts, J Cell Biol, 122, 103, 10.1083/jcb.122.1.103 Vyalov, 1993, GM-CSF-induced granulation tissue formation, Virchows Arch B Cell Pathol Mol Pathol, 63, 231, 10.1007/BF02899267 Gharaee-Kermani, 2001, Role of cytokines and cytokine therapy in wound healing and fibrotic diseases, Curr Pharm Des, 7, 1083, 10.2174/1381612013397573 Desmouliere, 1997, Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury, Int J Biochem Cell Biol, 29, 19, 10.1016/S1357-2725(96)00117-3 Desmouliere, 1995, Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar, Am J Pathol, 146, 56 Zhang, 1999, Inhibition of myofibroblast apoptosis by transforming growth factor β1, Am J Respir Cell Mol Biol, 21, 658, 10.1165/ajrcmb.21.6.3720 Navas-Palacios, 1984, Inclusion body myofibroblasts other than those seen in recurring digital fibroma of childhood, Ultrastruct Pathol, 7, 109, 10.3109/01913128409141468